Questions For the Star Scientific Experts:
Hello,
I'm considering taking a position in STSI, and I have some questions that concern me. If you can answer any one of the following questions, or guide me to the answer, it would be helpful (you don't have to know the answers to them all).
They are:
1. Is there a lockup period for the recent warrant conversion? Do you know if these new holders plan to sell their shares anytime soon? They got to exercise their warrants for quite a bit less than the market price for the stock.
2. Why did quarter on quarter growth slow down so much from Q2 to Q3? It went from 36% growth in Q2 to only 10% growth in Q3. What is the expected growth in Q4 and 2013?
3. Why is the gross margin so different in each quarter? In Q1 it was 21%, Q2 33%, and Q3 10%. Has the ingredients to Anatabloc gotten more expensive?
4. Are there any catalysts for the company coming up in 2013?
5. Why did the company only get $5 million for the RJR verdict? Wasn't it supposed to be in the hundreds of millions?
6. The CEO is only taking $1 per month in compensation until the company becomes profitable. Does that mean he won't get any share based compensation either? How does he plan to make the company profitable? Will it be only if anatabloc gets approval as a prescription drug?
Thanks in advance.
